A recent study from the National Drug and Alcohol Research Centre at UNSW Sydney reveals that over half of surveyed individuals who use illicit drugs have also used ADHD medications without a prescription. The 2024 report surveyed 740 regular users of ecstasy and other stimulants in Australia, finding that 54% had taken pharmaceutical stimulants like methylphenidate (Ritalin) and dexamphetamine in the past six months—marking the highest rate since tracking began in 2007.
Pharmaceutical stimulants are commonly prescribed for ADHD and narcolepsy, functioning by increasing levels of neurotransmitters such as dopamine. However, their non-prescribed use has surged, with motivations ranging from enhancing alertness and concentration to recreational use. Since 2007, the rate of non-prescribed use has tripled, rising from 17% to 54%.
While most respondents reported infrequent use—typically monthly or less—79% indicated that obtaining these substances was easy. The survey also noted increasing instances of poisoning related to misuse, highlighting potential risks like acute cardiac events and adverse effects when combined with other drugs.
Given these findings, experts suggest implementing harm reduction campaigns to educate users about the risks associated with non-prescribed stimulant use, alongside ongoing monitoring of related health impacts.
